Search

Author/Creator Goessl, Carsten

1. Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 7 (July 2018)

Authors:
Clarke, Noel; Wiechno, Pawel; Alekseev, Boris; Sala, Nuria; Jones, Robert; Kocak, Ivo; Chiuri, Vincenzo Emanuele; Jassem, Jacek; Fléchon, Aude; Redfern, Charles; Goessl, Carsten; Burgents, Joseph; Kozarski, Robert; Hodgson, Darren; Learoyd, Maria; Saad, Fred
Journal:
Lancet oncology
Issue:
Volume 19:Issue 7(2018)
Page Start:
975
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. (October 2019)

Authors:
Robson, Mark; Ruddy, Kathryn J.; IM, Seock-Ah; Senkus, Elżbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Li, Wei; Tung, Nadine; Armstrong, Anne; Delaloge, Suzette; Bannister, Wendy; Goessl, Carsten; Degboe, Arnold; Hettle, Robert; Conte, Pierfranco
Journal:
European journal of cancer
Issue:
Volume 120(2019)
Page Start:
20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search